Drug details

Cysview (hexaminolevulinate hydrochloride intravesical solution)

type of Contrast Media, Other

Cysview (hexaminolevulinate hydrochloride) is an imaging drug used in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. Cysview is used with the Karl Storz D-Light C Photodynamic Diagnostic (PDD) system to perform cystoscopy with the blue light setting (Mode 2) as an adjunct to the white light setting (Mode 1).

This drug may have the following side effects:

• hives,
• difficulty breathing, and
• swelling of your face, lips, tongue, or throat

The following drugs are related to Cysview, either as a replacement or used together:

• Tecentriq (atezolizumab injection)
• Theracys (bcg live (intravesical))
• MD-Gastroview (diatrizoate meglumine and diatrizoate sodium solution)
• Sancuso (granisetron transdermal system)
• Oraltag (iohexol for oral solution)
• Valstar (valrubicin)